Results 211 to 220 of about 499,895 (395)

Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy. [PDF]

Egypt Heart J
Ogieuhi IJ, Ajekiigbe VO, Adeyemi BA, Nwatamole B, Ayodeji KB, Ugiomoh OM, Odeniyi TA, Akingbola A, Iyawe EP, Oladejo OO, Lawal MO, Woldehana NA, Bakare IS, Patience AT, Okoro GC.   +14 more
europepmc   +1 more source

Coronary artery bypass grafting in a patient with hypertrophic non-obstructive cardiomyopathy. A case report.

, 1990
Hideki Nakahara, Takashi Yamada, Yoshihito Irie, Motoki YOKOYAMA, N Ohshima, S Tanabe   +5 more
openalex   +2 more sources

Non-surgical myocardial reduction for patients with hypertrophic obstructive cardiomyopathy [PDF]

, 2001
Ulrich Sigwart
openalex   +1 more source

Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.

Journal of the American College of Cardiology, 2022
H. Cui, H. Schaff, Shuiyun Wang, B. Lahr, E. Rowin, H. Rastegar, Shengshou Hu, M. Eleid, J. Dearani, C. Kimmelstiel, B. Maron, R. Nishimura, S. Ommen, M. Maron   +13 more
semanticscholar   +1 more source

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source

INFECTIVE ENDOCARDITIS DUE TO GEMELLA-MORBILLORUM COMPLICATING HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [PDF]

, 1994
Campbell, NP, Kerr, JR, McGimpsey, JG, Webb, CH   +3 more
core   +1 more source

MRI Versus 3D Echocardiography in Postinterventional Patients With Hypertrophic Obstructive Cardiomyopathy [PDF]

, 2001
Andreas Franke, Harald P. Kühl, Friedrich A. Schoendube   +2 more
openalex   +1 more source

Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification

ESC Heart Failure, EarlyView.
Abstract Clinical endpoint classification (CEC)—that is, evaluation of clinical events using pre‐defined criteria—is commonly conducted in clinical trial operations to ensure systematic and consistent assessment of endpoints needed to assess the intervention's safety and efficacy.
Veraprapas Kittipibul, Harriette G.C. Van Spall, William Schuyler Jones, Marat Fudim, Robert J. Mentz, Kevin Anstrom, Bertram Pitt, Patrice Desvigne‐Nickens, Jerome L. Fleg, Camilla Hage, Stefan James, Claes Held, Lars Lund, Adam DeVore   +13 more
wiley   +1 more source

Investigating the Anrep Effect in Hypertrophic Obstructive Cardiomyopathy With Invasive Pressure-Volume Analysis. [PDF]

JACC Adv
Reil JC, Sequeira V, Reil GH, Scholtz S, Rudolph V, Maack C, Serruys P, Steendijk P.   +7 more
europepmc   +1 more source

Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy—The lobster claw abnormality

, 1997
Mark V. Sherrid, David Z. Gunsburg, Gretchen Pearle   +2 more
openalex   +1 more source